Results 11 to 20 of about 138,518 (265)

Prevention and control of chicken coccidiosis construction of recombinant Lactococcus lactis expressing chicken IL-4 and IL-2 fusion protein and its immune synergistic effect on chicken coccidia live vaccine

Poultry Science, 2023
: Intestinal mucosa injury and loss of weight gain are unavoidable while using live vaccine strain to prevent chicken coccidiosis. In this study, recombinant Lactococcus lactis NZ3900/pNZ8149-IL-4-IL-2, expressing the fusion protein of chicken IL-4 and ...
Longlong Zheng, Li Zhang, Fan Tan, Chen Wang, Xiaoling Lv, Rui Bai, Nairui Huo, Mingxue Zheng   +7 more
doaj   +1 more source

Safety and Immunogenicity of a novel three-dose recombinant nanoparticle rabies G protein vaccine administered as simulated post exposure immunization: A randomized, comparator controlled, multicenter, phase III clinical study

Human Vaccines & Immunotherapeutics, 2021
Background Rabies vaccines are lifesaving in human post animal exposure. However, the compliance to the complete course of vaccine is found to be only 60%.
Ravish H S, Akash Khobragade, Durga Satapathy, Monica Gupta, Surendra Kumar, Vinay Bhomia, Ramasubramanian V, Maharshi Desai, Ashok Dilipkumar Agrawal   +8 more
doaj   +1 more source

Prevention of Herpes Zoster: A Focus on the Effectiveness and Safety of Herpes Zoster Vaccines

Viruses, 2022
Infection with varicella zoster virus typically occurs in children and it can cause primary varicella infection or “chickenpox”, or it can reactivate later in life and cause herpes zoster or “shingles”.
Yasmin Marra, Fawziah Lalji
doaj   +1 more source

Antibody response to Newcastle disease virus recombinant fusion protein in post-vaccinated laying hens

Journal of the Indonesian Tropical Animal Agriculture, 2023
This research was aimed to analyze antibody response in laying hens post vaccinated by Newcastle Disease Virus (NDV) recombinat Fusion (F) protein which has been succesfully expressed from the F gene of local isolates of NDV from Kulon Progo strain (0663/
J. Jawad, R. W. Astuti, A. Haryanto, N. Wijayanti   +3 more
doaj   +1 more source

Zika Virus Envelope Domain III Recombinant Protein Delivered With Saponin-Based Nanoadjuvant From Quillaja brasiliensis Enhances Anti-Zika Immune Responses, Including Neutralizing Antibodies and Splenocyte Proliferation

Frontiers in Immunology, 2021
Nanoadjuvants that combine immunostimulatory properties and delivery systems reportedly bestow major improvements on the efficacy of recombinant, protein-based vaccines.
Samuel Cibulski, Ana Paula Muterle Varela, Thais Fumaco Teixeira, Martín Pablo Cancela, Patrícia Sesterheim, Diogo Onofre Souza, Paulo Michel Roehe, Fernando Silveira   +7 more
doaj   +1 more source

Recombination of Goose Parvovirus VP3 Gene and Goose Interferon Ɣ Gene from Fowlpox Virus Immune Protection and Its Mechanism [PDF]

BIO Web of Conferences, 2023
Gosling plague (GP) is caused by goose parvovirus (GPV) gosling acute, subacute, and septic infectious diseases, commonly known as gosling plague. At present, the prevention and control of GP at home and abroad mainly adopts the method of immunizing ...
Ma Haoyuan, Xue Haowen, Fu Jingfeng, Song Yanhao, Zhu Kunru, Gao Xu   +5 more
doaj   +1 more source

Recombinant LSDV Strains in Asia: Vaccine Spillover or Natural Emergence?

Viruses, 2022
From 2017 to 2019, several vaccine-like recombinant strains of lumpy skin disease virus (LSDV) were discovered in Kazakhstan and neighbouring regions of Russia and China.
Frank Vandenbussche, Elisabeth Mathijs, Wannes Philips, Meruyert Saduakassova, Ilse De Leeuw, Akhmetzhan Sultanov, Andy Haegeman, Kris De Clercq   +7 more
doaj   +1 more source

Oral immunization with a live coxsackievirus/HIV recombinant induces gag p24-specific T cell responses. [PDF]

PLoS ONE, 2010
The development of an HIV/AIDS vaccine has proven to be elusive. Because human vaccine trials have not yet demonstrated efficacy, new vaccine strategies are needed for the HIV vaccine pipeline.
Rui Gu, Anae Shampang, Toufic Nashar, Manisha Patil, Deborah H Fuller, Arlene I Ramsingh   +5 more
doaj   +1 more source

Environmental Risk Assessment of Recombinant Viral Vector Vaccines against SARS-Cov-2

Vaccines, 2021
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the coronavirus disease 2019 (COVID-19) pandemic. Over the past months, considerable efforts have been put into developing effective and safe drugs and vaccines ...
Aline Baldo, Amaya Leunda, Nicolas Willemarck, Katia Pauwels   +3 more
doaj   +1 more source

Prime-boost with Mycobacterium smegmatis recombinant vaccine improves protection in mice infected with Mycobacterium tuberculosis. [PDF]

PLoS ONE, 2013
The development of a new vaccine as a substitute for Bacillus Calmette-Guerin or to improve its efficacy is one of the many World Health Organization goals to control tuberculosis.
Ana Paula Junqueira-Kipnis, Fábio Muniz de Oliveira, Monalisa Martins Trentini, Sangeeta Tiwari, Bing Chen, Danilo Pires Resende, Bruna D S Silva, Mei Chen, Lydia Tesfa, William R Jacobs, André Kipnis   +10 more
doaj   +1 more source